Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000992610 | SCV001145017 | uncertain significance | not provided | 2019-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000992610 | SCV002578535 | uncertain significance | not provided | 2023-12-06 | criteria provided, single submitter | clinical testing | In-frame deletion of 3 amino acids in a non-repeat region; In silico analysis supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Diagnostic Laboratory, |
RCV000992610 | SCV001978483 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000992610 | SCV001980489 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003943300 | SCV004762698 | likely benign | PKD1-related disorder | 2022-12-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |